26th Annual National Conference
Printable Schedule-at-a-Glance (Updated: 9/19/17)
MONDAY, OCTOBER 2, 2017
Up to 5.0 continuing education credits available.
ACPE UAN 0860-0000-17-025-L01-P/0860-0000-17-025-L01-T (.50 CEUs)
Registration and Continental Breakfast
Welcome and Opening Remarks, Heidi Leenay, Vice President, OptumHealth Education
KEYNOTE ADDRESS — Delivering High-Quality Care to Diverse Populations: Pursuing Value and Equity in a Time of Health Care Transformation, Joseph R. Betancourt, MD, MPH, Disparities Solutions Center and Massachusetts General Hospital
Improving quality, achieving equity and pursuing value in health care will be essential in a time of increasing diversity and rapid transformation. Research has shown that minorities, and other vulnerable populations, receive lower quality health care, even when they have the same insurance as their majority counterparts. The Institute of Medicine’s seminal reports “Crossing the Quality Chasm” and “Unequal Treatment” both highlight the root causes of these disparities and variations in quality and provide a blueprint for action. This presentation will highlight these and more current findings, along with some practical, actionable health care strategies — including the incorporation of cross-cultural care, or cultural competence — which will improve quality, achieve equity, and drive towards value.
Current and Future Applications of Gene Therapy, Andrew M. Davidoff, MD, St. Jude Children's Research Hospital
Gene therapy involves altering the genes inside the body’s cells in an effort to treat or stop disease. Either a faulty gene is replaced or a new gene is added in an attempt to cure disease or improve the body’s ability to fight disease. Important medical advances in gene therapy have been achieved during the past few years, with clinical translational trials underway for a wide range of deadly diseases. Among the most notable advancements are gene therapy for genetic disorders, such as severe combined immune deficiency (SCID), chronic granulomatus disorder (CGD) and hemophilia; and for acquired diseases such as cancer, Parkinson’s and Huntington’s diseases, HIV, heart disease, and diabetes. This session will review the role of gene therapy in the treatment of hereditary diseases, with a focus on hemophilia.
Advances in CAR T-Cell Immunotherapy in Leukemia, Shannon L. Maude, MD, PhD, The Children’s Hospital of Philadelphia
Chimeric antigen receptor (CAR) T-cell therapy continues to have impressive showings in patients with aggressive hematologic malignancies with no other promising treatment options. This session will discuss outcomes when using T-cell immunotherapy against relapsed or refractory acute lymphoblastic leukemia (ALL).
Luncheon Presentation (nonaccredited/optional; lunch provided)
Exhibit Hall Grand Opening Dessert Reception
Metabolic Surgery and Transplantation, Tayyab S. Diwan, MD, University of Cincinnati Medical Center
Obesity in transplantation has become prevalent and presents a difficult dilemma for transplant programs. Many transplant centers consider obesity a relative contraindication for transplant due to the associated risks of surgical complications. There are limited clinical alternatives for the management of obesity in the transplant patient other than metabolic surgery, diet and exercise. This session will discuss the safety and efficacy of metabolic surgery, including the sustainability of weight control over the long term and its effect on posttransplant weight gain.
The Impact of Frailty on Posttransplant Outcomes, Michelle James, MS, RN, CNS, CCTN, APRN-BC, and Michael Petty, PhD, RN, CCNS, ACNS-BC, University of Minnesota Health
Frailty impacts various general aspects of health care and, in particular, organ transplantation, including patient selection, waitlist management and treatment posttransplant. In general, frailty has been characterized by a compromised physiological reserve. In comparison to healthy aging, inflammatory markers and cytokines are increased in frail older adults. Thus, modifications of the immune response, in addition to physical limitations and changes of metabolism, are likely to impact outcomes after transplantation. This session will discuss the importance of a risk assessment of frailty at the time of transplant evaluation and review effects on outcomes and recovery posttransplant.
Increasing Living Donation in Minorities: Special Focus on Hispanics, Juan C. Caicedo, MD, Northwestern Medicine; Soledad Mendoza, Kidney Transplant Donor and Alberto Orozco, Kidney Transplant Recipient
For Hispanic/Latino individuals, not having a Spanish-speaking health care provider to help guide them through the transplant process can mean unnecessary suffering and even death. Having a transplant program tailored for the Hispanic and Latino communities with a bilingual team of surgeons, nurses, social workers, transplant specialists, and support staff can make life-saving surgeries more accessible by removing cultural and linguistic barriers. This presentation will include participation from the director of a Hispanic transplant program, as well as a transplant donor and recipient that received care through this culturally sensitive program. The panel will share their experiences and discuss how the program helps patients and their families learn about the options, risks, and benefits of living- and deceased-donor-kidney transplants so they can make informed decisions about what is best for them.
Happy Hour Networking Reception — Exhibits Open
TUESDAY, OCTOBER 3, 2017
Up to 5.5 continuing education credits available.
ACPE UAN 0860-0000-17-026-L01-P/0860-0000-17-026-L01-T (.55 CEUs)
10th Annual Wellness Walk
Registration and Continental Breakfast — Exhibits Open
Welcome and Opening Remarks, Heidi Leenay, Vice President, OptumHealth Education
Have We Achieved Pareto Optimality or Pareto Efficiency in Transplantation? Michael Abecassis, MD, MBA, Northwestern University
Pareto optimality is a formally defined concept used to judge the efficiency of a distribution when shared goods or resources are allocated to many. Pareto efficiency occurs when all resources are exhausted, and any change in allocation will make at least one party worse off. During this session, Dr. Abecassis will discuss similarities and differences between Pareto optimality, equity, and social optimality in order to provide a conceptual framework to better understand the dynamics and behaviors we are currently witnessing in national debates around liver allocation.
The Fight Against the Opioid Epidemic, William B. Leasure, MD, Mayo Clinic
Opioid abuse is a serious public health issue. Drug overdose is a leading cause of injury death in the United States, and there is a clear correlation between opioid-prescribing rates and overdose death rates. This fact accentuates the importance of prescribing guidelines that encourage the use of opioids only when benefits outweigh risks and that promote safe use when opioids are needed. This session will discuss opioid-prescribing guidelines for chronic pain; the clinical decision-making process to reduce inappropriate opioid prescribing; and how organ donations have increased in the wake of the opioid epidemic.
Break — Exhibits Open
Lunch — Exhibits Open
Cardiovascular Disease: Guidelines and Challenges in Patient Management, Haitham Ahmed, MD, MPH, Cleveland Clinic
In 2013, the American College of Cardiology (ACC) and the American Heart Association (AHA), developed new guidelines for the treatment of blood cholesterol and risk assessment of atherosclerotic cardiovascular disease (ASCVD). The new guidelines recommend the use of statin therapy as the medication of choice in ASCVD risk reduction. This was a major shift from the old approach, creating controversies and a state of confusion. As a result of these new guidelines, health care providers require additional information about how to prevent, treat and manage risk factors for cardiovascular disease. This session will provide insight into the application of these new guidelines to current cardiovascular practices, identify challenges and barriers faced by health care providers, and demonstrate the importance of an interdisciplinary team in the care of patients with cardiovascular disease.
Chronic Kidney Disease (CKD) Continuum: The Relationship Between Obesity, Diabetes, Cardiovascular Disease and Transplant, Jane C. Tan, MD, Stanford University Medical Center
CKD is associated with an increased risk for cardiovascular disease, progression to end-stage-renal disease (ESRD) and potentially the need for a kidney transplant. This session will explore the relationship between obesity, diabetes, kidney disease, cardiovascular disease and transplant; the challenges of meeting evidence-based guidelines for managing CKD; and the benefits of addressing multiple risk factors simultaneously and the impact on outcomes.
Break — Exhibits Open
Diabetes: Improvements in Prevention and Care, Ruchi Mathur, MD, FRCP(C), Cedars-Sinai Medical Center
In the United States, an estimated 86 million people are living with prediabetes and 29 million are living with diabetes. Lifestyle management is a fundamental aspect of diabetes care. There is strong and consistent evidence that obesity management can delay the progression of diabetes, and screening and interventions can limit organ damage. Therefore, diabetes patients require initial and ongoing evaluation for diabetes and its related complications. This session will review medical management approaches consistent with guidelines from the American Diabetes Association (ADA) for health maintenance in patients with diabetes and identify barriers for screening patients at increased risk for diabetes. The importance of an interdisciplinary team approach will also be discussed.
Sickle Cell Disease (SCD): Panel Discussion, Lakshmanan Krishnamurti, MD, Children’s Healthcare of Atlanta/Emory University, and Ines Lukombo, Transplant Recipient
SCD is the most common inherited hemoglobin disorder, affecting 70,000–100,000 people in the U.S. Allogeneic hematopoietic stem cell transplant (HSCT) is currently the only curative treatment for severe SCD that offers excellent long-term survival, but access is limited for several reasons, including donor availability, as well as sociocultural and economic barriers. For our last session of the day, an HSCT recipient will share her experience undergoing transplant for SCD and a renowned hematologist will provide an overview of SCD and review evidence-based guidelines for referral and shared decision making. Treatment options including standard of care and curative therapies, and their outcomes will be addressed.
Optum Provider Network Reception (Ticketed event; by invitation only.)
WEDNESDAY, OCTOBER 4, 2017
Up to 2.75 continuing education credits available.
ACPE UAN 0860-0000-17-027-L01-P/0860-0000-17-027-L01-T (.275 CEUs)
Optum Client Breakfast: Perspectives on Transplantation — from the patient, caregiver and nurse case manager’s point of view (Ticketed, nonaccredited event; by invitation only.)
Predicting Risk: Current Research and New Therapies for Optimal Management of Colorectal Cancer, Kristen K. Ciombor, MD, MSCI, Vanderbilt University Medical Center
Colorectal cancer is a leading cause of cancer-related deaths in the United States. Research is always going on in this area of medicine, leading to great progress in recent discoveries of new and improved treatment and screening strategies. Tests have been developed to find genetic changes associated with colorectal cancer and to predict the risk of cancer recurrence. Identifying these genes can help doctors and individuals decide on their treatment options to extend survival and improve quality of life. This session will discuss management strategies for colorectal cancer, including how health disparities negatively impact colorectal cancer screening rates, and describe the exploration of new therapeutic avenues intended to enhance outcomes and improve detection methods.
Integrating Telemedicine into Health Care Delivery for the Transplant Population, David Mulligan, MD, FACS, Yale-New Haven Transplantation Center
Telemedicine has continued to grow as a unique way of delivering care to patients, while greatly improving access, reducing cost and positively impacting quality. Dr. Mulligan has been incorporating telehealth in the form of videoconferencing into the transplant setting, thus saving patients the effort of traveling to their follow-up appointments, taking time off work and avoiding potential exposure to other patients while they have a weakened immune system. With a focus on patients that undergo transplantation, Dr. Mulligan will discuss the challenges of integrating telemedicine into health care and its potential impact on improving health care quality, access, equity, and affordability.
Transitioning from Pediatric to Adult Transplant Care for Solid Organ Transplants, Saeed Mohammad, MD, Ann & Robert H. Lurie Children's Hospital of Chicago
The transition of health care for adolescents with solid organ transplants as they move into adult-centered services has become more significant over recent years as survival has improved. Since the transfer process from pediatric to adult care can be a challenging phase for transplant recipients, their families, and providers, transition planning should begin at an early age and be an integral component of their ongoing care. This session will address the potential challenges and psychosocial factors associated with transitioning from pediatric to adult transplant care.
Note: OptumHealth Education reserves the right to make any necessary changes to this program. Efforts will be made to keep presentations as scheduled. However, unforeseen circumstances may result in the substitution of faculty or content.
Last updated: 09/21/17